ESTRO 36 Programme book and exhibition guide

INTERDISCIPLINARY RADIOBIOLOGY CLINICAL BRACHYTHERAPY PHYSICS RTT YOUNG

SATURDAY 6 MAY 2017

09:35 > Evaluation of time, attendance of medical staff,and resources during stereotactic radiotherapy/radiosurgery: QUIRO-DEGRO trial Speaker: J. Hörner-Rieber (Germany)

SP-0027

SYMPOSIUMWITH PROFFERED PAPERS Novel approaches in heart / lung matters 08:45 - 10:00 | LEHAR 4

Recent data suggesting that cardiac toxicity is not an exclusively late occurring complication has revived that interest in it mechanistic basis and approaches for prevention and treatment. Therefore, pathogenic mechanisms, associated therapeutic targets and experimental work testing potential therapeutics to modulate the induction of cardiac damage by (chemo-) radiotherapy, will be discussed.

Chair: P. Van Luijk (The Netherlands) Co-chair: A. De Vries (Austria)

08:45 > State of the art in heart effects M.C. Vozenin (Switzerland)

SP-0028

09:12 > Pharmacological modulation of cardiac radiation injury M. Boerma (USA) 09:39 > In vitro study of FLASH vs. conventional dose-rate irradiation: Cell viability and DNA damage repair A. Beddok (France), C. Fouillade, E. Quelennec, V. Favaudon 09:49 > Global changes in the glycosylation of irradiated endothelial cells with functional consequences C. Jaillet, W. Morelle, M.C. Slomianny, V. Paget, G. Tarlet, V. Buard, S. Selbonne, F. Caffin, E. Rannou, P. Martinez, A. François, F. Foulquier, F. Allain, F. Milliat, O. Guipaud (France)

SP-0029

OC-0030

OC-0031

SYMPOSIUM Expanding brachytherapy indications 08:45 - 10:00 | STOLZ 1-2

Integrating modern imaging modalities or tools of interventional radiology as part of the management of cancer patients might provide new opportunities for brachytherapy in a variety of indications. In fact, the next step of treatment optimisation in brachytherapy might rely on multidisciplinary therapeutic strategies, based either on a more accurate definition of target volumes, or providing a minimally invasive access to treat target lesions in deep anatomic sites or close to critical organs. This session will give an overview on how could brachytherapy indications be expanded or refined by a comprehensive integration of high-tech

Programme and Exhibition Guide | SCIENTIFIC PROGRAMME

77